These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32732858)

  • 41. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
    Loggi E; Conti F; Cucchetti A; Ercolani G; Pinna AD; Andreone P
    World J Gastroenterol; 2016 Sep; 22(35):8010-6. PubMed ID: 27672295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.
    Huprikar S; Danziger-Isakov L; Ahn J; Naugler S; Blumberg E; Avery RK; Koval C; Lease ED; Pillai A; Doucette KE; Levitsky J; Morris MI; Lu K; McDermott JK; Mone T; Orlowski JP; Dadhania DM; Abbott K; Horslen S; Laskin BL; Mougdil A; Venkat VL; Korenblat K; Kumar V; Grossi P; Bloom RD; Brown K; Kotton CN; Kumar D
    Am J Transplant; 2015 May; 15(5):1162-72. PubMed ID: 25707744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience.
    Horan JL; Stout JE; Alexander BD
    Transpl Infect Dis; 2014 Oct; 16(5):859-63. PubMed ID: 25154437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation.
    Fernández I; Pascasio JM; Colmenero J; ;
    Gastroenterol Hepatol; 2020 Mar; 43(3):169-177. PubMed ID: 32094045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. De Novo Hepatitis B Infection From Hepatitis B Core Antibody-Positive Donors During Hepatitis B Immunoglobulin Prophylaxis.
    Shin M; Chang SH
    Exp Clin Transplant; 2016 Feb; 14(1):106-8. PubMed ID: 26325029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain.
    Sánchez Ibáñez J; Vilarrodona Serrat A; Seoane Pillado T; Rodriguez Aierbe C; Villalba Montoro R; Calvo Benito J; Pevida Lopez M; Fernández Paneque S; Vuelta Lopez E; Martínez Lorenzo MJ; González Romero M; Cañizares Castellanos A; Sauleda Oliveras S
    Cell Tissue Bank; 2019 Dec; 20(4):513-526. PubMed ID: 31451994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention.
    Sagnelli C; Pisaturo M; Calò F; Martini S; Sagnelli E; Coppola N
    World J Gastroenterol; 2019 Jul; 25(26):3299-3312. PubMed ID: 31341357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
    Nery JR; Nery-Avila C; Reddy KR; Cirocco R; Weppler D; Levi DM; Nishida S; Madariaga J; Kato T; Ruiz P; Schiff E; Tzakis AG
    Transplantation; 2003 Apr; 75(8):1179-86. PubMed ID: 12717200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B after transplantation: competition between the recipient virus and the donor virus.
    Mutimer D
    Liver Transpl; 2010 Nov; 16(11):1225-7. PubMed ID: 21031536
    [No Abstract]   [Full Text] [Related]  

  • 52. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
    J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus).
    Natov SN; Pereira BJ
    Transpl Infect Dis; 2002 Sep; 4(3):117-23. PubMed ID: 12421455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B prophylaxis in hepatitis B-negative recipients transplanted with donor grafts positive for hepatitis B core antibodies.
    Scuderi V; Ceriello A; Santaniello W; Aragiusto G; Romano M; Migliaccio C; Calise F
    Transplant Proc; 2011; 43(1):271-3. PubMed ID: 21335203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
    Dodson SF
    Clin Transplant; 2000; 14 Suppl 2():20-4. PubMed ID: 10965960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
    Udayakumar VP; Surendran S; Padma UD
    Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Radhakrishnan K; Chi A; Quan DJ; Roberts JP; Terrault NA
    Transplantation; 2017 Sep; 101(9):2079-2082. PubMed ID: 28880197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.